===
EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Quarter Results/Quarter Results
RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter
2024-05-08 / 08:59 CET/CEST
The issuer is solely responsible for the content of this announcement.
Corporate News
Bad Neustadt a. d. Saale | 8 May 2024
RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter

RHÖN-KLINIKUM AG, one of the leading healthcare providers in Germany, has made a solid start to financial year 2024.
Both consolidated profit and EBITDA as well as revenues rose in the first three months.
Revenues increased by 5.9% to EUR382.8 million (Q1 2023: EUR361.5 million). At EUR25.2 million, EBITDA (earnings before
interest, taxes, depreciation and amortisation) was 12% higher than the previous year (Q1 2023: EUR22.5 million). Taking
into account depreciation, amortisation, financing costs and taxes, EBITDA resulted in a consolidated profit of EUR11.1
million (Q1 2023: EUR6.4 million). From January to March 2024, 234,151 outpatients and inpatients were treated in the
Group's hospitals and medical care centers (Q1 2023: 228,189).
"RHÖN-KLINIKUM AG considers itself well prepared for the forthcoming hospital reform with positioning of its hospitals.
With our RHÖN Campus concept, the growing range of outpatient treatment services and the establishment of new medical
services, we are seizing opportunities that we will implement for the benefit of our patients", says Prof. Dr Tobias
Kaltenbach, Chairman of the Board of Management of RHÖN-KLINIKUM AG.
Outlook for 2024 confirmed
For the coming financial year, RHÖN-KLINIKUM AG expects revenues of EUR1.6 billion euros within a range of +/- 5% upwards
and downwards respectively. For earnings before interest, tax and depreciation and amortisation (EBITDA), a level of
between EUR110 million euros and EUR120 million is expected.
This outlook reflects the further tightening of regulatory intervention by the legislator. RHÖN-KLINIKUM AG points out
that the outlook is subject to considerable uncertainties in connection with the numerous global crises resulting in
inflation and price increases and subject to any regulatory intervention causing the remuneration structure in 2024.
Quarterly Statement - Q1 2024

RHÖN-KLINIKUM AG is one of the leading healthcare providers in Germany. The hospitals offer excellent medical care with
a direct tie-in to universities and research facilities. Each year some 882,000 patients are treated at our five sites
- RHÖN-KLINIKUM Campus Bad Neustadt, Klinikum Frankfurt (Oder), Universitätsklinikum Gießen and Universitätsklinikum
Marburg (UKGM) as well as Zentralklinik Bad Berka. The Company employs over 18,200 persons. The innovative RHÖN Campus
approach committed to cross-sector and future-oriented healthcare delivery in rural areas, the steadfast continuation
of the gradual digital transformation within the Company as well as the strategic partnership with Asklepios are key
elements of our corporate strategy. RHÖN-KLINIKUM AG is an independent Company operating under the umbrella of
Asklepios Kliniken GmbH & Co. KGaA. www.rhoen-klinikum-ag.com
Contact:
RHÖN-KLINIKUM AG |Head of Corporate Finance, Treasury, Investor Relations and Sustainability
Julian Schmitt
T. +49 9771 65-12250 | julian.schmitt@rhoen-klinikum-ag.com
RHÖN-KLINIKUM AG | Schlossplatz 1 | D-97616 Bad Neustadt a. d. Saale
2024-05-08 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com  
Language:     English 
Company:      RHÖN-KLINIKUM Aktiengesellschaft 

Salzburger Leite 1
97616 Bad Neustadt a.d.Saale
Germany

Phone:        +49 (0)9771 - 65-0 
Fax:          +49 (0)9771 - 97 467 
E-mail:       rka@rhoen-klinikum-ag.com 
Internet:     www.rhoen-klinikum-ag.com 
ISIN:         DE0007042301 
WKN:          704230 
Listed:       Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, 

Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange
EQS News ID: 1898205

End of News EQS News Service
===
1898205 2024-05-08 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1898205&application_name=news

END) Dow Jones Newswires

May 08, 2024 03:00 ET (07:00 GMT)